(2025). A decade of progress in type 2 diabetes and cardiovascular disease: Advances in SGLT2 inhibitors and GLP-1 receptor agonists – a comprehensive review.
Chicago Style (17th ed.) CitationA Decade of Progress in Type 2 Diabetes and Cardiovascular Disease: Advances in SGLT2 Inhibitors and GLP-1 Receptor Agonists – a Comprehensive Review. 2025.
MLA (8th ed.) CitationA Decade of Progress in Type 2 Diabetes and Cardiovascular Disease: Advances in SGLT2 Inhibitors and GLP-1 Receptor Agonists – a Comprehensive Review. 2025.
Warning: These citations may not always be 100% accurate.